Dr. Paolo Rossato

Associate Director, PK & QSP Unit, Pharmacology & Toxicology Department, Research
CSL Behring, Germany
Paolo is a pharmaceutical scientist with long experience in Pharma companies and also in a Contract Research Organization. Currently he works at CSL Behring in the PK & QSP Unit of the Department of Pharmacology & Toxicology, providing ADME, PK, and PK/PD support for research programs in different therapeutic areas. After his degree in Chemistry, Paolo worked for more than 20 years in GlaxoSmithKline in the Drug Metabolism and Pharmacokinetics Department, in both Discovery and Development phases, mainly in CNS diseases and small molecules. Over the years, he covered almost all the roles in the Department (LC-MS Bioanalyst, Pharmacokineticist, Toxicokineticist and Study Director). He was also Laboratory Head with the responsibility of almost all in vitro and in vivo DMPK/ADME studies. He was a Senior Scientist in PK, PK/PD and TK data analysis, modeling and simulation and DMPK Project Representative in different Project Teams, in various therapeutic areas. After this experience, he worked for 3 years in a Contract Research Organization, Aptuit, always in the DMPK Department. Here he expanded his experience in almost all therapeutic areas and types of molecules. Then, Paolo joined Baxter/Baxalta/Shire and finally Takeda in the Pharmacology Department of Drug Discovery, where he focused for 6 years on biologics mainly in the Hematology area. He was responsible for all in vitro and in vivo DMPK/ADME studies, worked as non-clinical project team member and was involved in non-clinical due diligence evaluations to support in-licensing.

Events/Masterclasses Dr. Paolo Rossato is currently speaking at

Pharma

Toxicology, ADME & Early Drug Development Plan
15 – 17 October 2024
Online Live Stream | 14:00 CEST – 18:00 CEST
Building an Integrated Safety Testing Strategy based on ADME and Toxicology. The purpose of this Toxicology, ADME & Early Drug Development Plan is to understand the concept of a combined ADME-Toxicology approach.

Are you interested in a custom-made event with this trainer?

Contact us to Request more information about your custom-made Corporate Learning program.

REQUEST MORE INFORMATION

Dr. Paolo Rossato
Associate Director, PK & QSP Unit, Pharmacology & Toxicology Department, Research
CSL Behring, Germany
Paolo is a pharmaceutical scientist with long experience in Pharma companies and also in a Contract Research Organization. Currently he works at CSL Behring in the PK & QSP Unit of the Department of Pharmacology & Toxicology, providing ADME, PK, and PK/PD support for research programs in different therapeutic areas. After his degree in Chemistry, Paolo worked for more than 20 years in GlaxoSmithKline in the Drug Metabolism and Pharmacokinetics Department, in both Discovery and Development phases, mainly in CNS diseases and small molecules. Over the years, he covered almost all the roles in the Department (LC-MS Bioanalyst, Pharmacokineticist, Toxicokineticist and Study Director). He was also Laboratory Head with the responsibility of almost all in vitro and in vivo DMPK/ADME studies. He was a Senior Scientist in PK, PK/PD and TK data analysis, modeling and simulation and DMPK Project Representative in different Project Teams, in various therapeutic areas. After this experience, he worked for 3 years in a Contract Research Organization, Aptuit, always in the DMPK Department. Here he expanded his experience in almost all therapeutic areas and types of molecules. Then, Paolo joined Baxter/Baxalta/Shire and finally Takeda in the Pharmacology Department of Drug Discovery, where he focused for 6 years on biologics mainly in the Hematology area. He was responsible for all in vitro and in vivo DMPK/ADME studies, worked as non-clinical project team member and was involved in non-clinical due diligence evaluations to support in-licensing.
Dr. Paolo Rossato
Description